The Right Ventricular Responses to Mild Hypercarbia After Mitral Valve Repair Surgery
NCT ID: NCT02757573
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2016-04-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients
NCT02728739
Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
NCT05011565
3D Ultrasound Myocardial Mechanical Wave Measurements
NCT06648577
Mitral Valve Reconstruction in Chronic Heart Failure (CHF): Identification of Predictors for a Successful Therapy
NCT00348829
Mechanisms of Right Ventricular Adaptation in Patients With Heart Failure With Preserved Ejection Fraction
NCT04154657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypercarbia
Hypercarbia: PaCO2 is elevated from 5 to 7.5 kPa by controlled ventilation.
Hypercarbia
PaCO2 is elevated from 5 to 7.5 kPa by controlled ventilation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypercarbia
PaCO2 is elevated from 5 to 7.5 kPa by controlled ventilation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to give informed consent
Exclusion Criteria
* significant tricuspid regurgitation
* congenital heart defect
* ventricular dyssynchrony or wide QRS-complex on ECG (\> 130 ms)
* prior myocardial infarction (within tree months) or pericardial constriction
* preoperative left ventricular (LV) dysfunction, i.e. LV ejection fraction under 40 %
* if the scheduled repair by plastic procedure has been converted to mitral valve replacement
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kati Järvelä
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kati Järvelä, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Kati Rautaneva, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital Heart Center
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tujunen MLJ, Lahti J, Kiiski H, Kuitunen AH, Tuohinen SS, Rautaneva K, Jalkanen VL, Huhtala H, Jarvela KM. Right Ventricular Response to Hypercapnia After Mitral Valve Repair: A Hemodynamic Assessment. Acta Anaesthesiol Scand. 2025 Jul;69(6):e70064. doi: 10.1111/aas.70064.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R16005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.